Do not discontinue GLP-1 therapy without medical guidance unless youre experiencing a serious adverse reaction, as sudden discontinuation can affect blood sugar management in patients with diabetes
Doctors typically start patients on the lowest dosage to allow the body to adjust
Discussing your symptoms can help doctors correctly adjust dosage and manage side effects
437 PC4 has been shown to mediate transcriptional activation of several oncogenes
The secondary outcomes were insulin, HOMA-IR, HbA1c, GLP-1, Glucagon, total cholesterol, triglycerides, HDL-C, low-density lipoprotein-cholesterol (LDL-C), ALP, AST, ALT, GT, TNF- , IL-6, hsCRP, antioxidant capacity and serum lipid peroxidation, body weight, body mass index (BMI), muscle mass, fat mass, and systolic and diastolic blood pressure Statistical analysis Sample size was established using the SigmaStat32 software, with significance level of 5% and 80% power